Home Newsletters Intestinal Cell News Synergistic Combination of PMBA and 5-Fluorouracil (5-FU) in Targeting Mutant KRAS in...

Synergistic Combination of PMBA and 5-Fluorouracil (5-FU) in Targeting Mutant KRAS in 2D and 3D Colorectal Cancer Cells

By
Justin.choi
-
0
Scientists investigated the effect and efficacy of 2-pyridin-4-yl methylene β-boswellic acid (PMBA) and 5-FU in combination therapy compared in the treatment of KRAS mutant colon cancer.
[Heliyon]
6445212 SPXSDFJC items 1 apa 0 default asc 1 173063 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
Full ArticleGraphical Abstract

RELATED ARTICLES

Exit mobile version